Metraipolis › archive › dc_f8b712077d2f

Taking Open Innovation to the Molecular Level - Strengths and Limitations — Europe PMC PMID:23226167

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/23226167
DOI
10.1002/minf.201200014
License (as archived)
solo-consultazione
Archived
2026-10-08T03:33:17.916Z
SHA-256 of the archived text
23cbee57d93cf8cd2185106c960fba078ba47a85376a3bbe53b57221e47a57ad
Stable URL of this page
https://metraipolis.com/documento/dc_f8b712077d2f

How to cite

Taking Open Innovation to the Molecular Level - Strengths and Limitations — Europe PMC PMID:23226167 — Europe PMC (en), https://europepmc.org/article/MED/23226167 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f8b712077d2f (Metraipolis archive dc_f8b712077d2f, sha256 23cbee57d93cf8cd2185106c960fba078ba47a85376a3bbe53b57221e47a57ad)
BibTeX
@misc{dcf8b712077d2f,
  title = {Taking Open Innovation to the Molecular Level - Strengths and Limitations — Europe PMC PMID:23226167},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/23226167},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f8b712077d2f; sha256 23cbee57d93cf8cd2185106c960fba078ba47a85376a3bbe53b57221e47a57ad},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/23226167. Agents can read the archived copy with the MCP tool read_document.